Beste apotheek van Nederland

Terradas C, Levalle O, Nagelberg A et al. Sildenafil improves
nocturnal penile erections in organic impotence. Int J Impot Res
2001;13(2):125-129.
Tomlinson John M, Wright David, E-Mail Address et al. Impact
of erectile dysfunction and its subsequent treatment with
sildenafil: Qualitative study. [References]. BMJ: British Medical
Journal 2004;328(7447):No
Tomsak R. PDE5 inhibitors and permanent visual loss. Int J
Impot Res 2005;17(6):547-549.
Tosti A, Pazzaglia M, Soli M et al. Evaluation of sexual function
with an international index of erectile function in subjects taking
finasteride for androgenetic alopecia.[see comment]. Arch
Dermatol 2004;140(7):857-858.
Trinchieri A, Nicola M, Masini F et al. Prospective
comprehensive assessment of sexual function after retropubic
non nerve sparing radical prostatectomy for localized prostate
cancer. Arch Ital Urol Androl 2005;77(4):219-223.
Truss M C, Becker A J, Thon W F et al. Intracavernous
calcitonin gene-related peptide plus prostaglandin E1: possible
alternative to penile implants in selected patients. Eur Urol
1994;26(1):40-45.
Tsai Y S, Lin J S, Lin Y M. Safety and efficacy of alprostadil
sterile powder (S. Po., CAVERJECT) in diabetic patients with
erectile dysfunction. Eur Urol 2000;38(2):177-183.
Tsujimura A, Yamanaka M, Takahashi T et al. The clinical
studies of sildenafil for the ageing male. Int J Androl
2002;25(1):28-33.
Turk S, Karalezli G, Tonbul H Z et al. Erectile dysfunction and
the effects of sildenafil treatment in patients on haemodialysis
and continuous ambulatory peritoneal dialysis.
Nephrol.Dial.Transplant. 2001;16(9):1818-1822.
Turner L A, Althof S E. The clinical effectiveness of selfinjection
and external vacuum devices in the treatment of
erectile dysfunction: a six-month comparison. Psychiatr Med
1992;10(2):283-293.
Turner L A, Althof S E, Levine S B et al. Twelve-month
comparison of two treatments for erectile dysfunction: selfinjection
versus external vacuum devices. Urology
1992;39(2):139-144.
Urciuoli R, Cantisani T A, CarliniI M et al. Prostaglandin E1 for
treatment of erectile dysfunction. Cochrane Database Syst Rev
2004;(2):CD001784
Valicenti R K, Choi E, Chen C et al. Sildenafil citrate effectively
reverses sexual dysfunction induced by three-dimensional
conformal radiation therapy. Urology 2001;57(4):769-773.
van Basten J P, Van Driel M F, Jonker-Pool G et al.
Sexual functioning in testosterone-supplemented
patients treated for bilateral testicular cancer. Br J
Urol 1997;79(3):461-467.
van Moorselaar R J, Hartung R, Emberton M et al.
Alfuzosin 10 mg once daily improves sexual function
in men with lower urinary tract symptoms and
concomitant sexual dysfunction. BJU Int
2005;95(4):603-608.
Van Ahlen H, Peskar B A, Sticht G et al.
Pharmacokinetics of vasoactive substances
administered into the human corpus cavernosum. Br J
Urol 1994;151(5):1227-1230.
Van Dijk M, Skrekas T, De La et al. The association
between lower urinary tract symptoms and sexual
dysfunction: Fact or fiction?. Curr Opin Urol
2005;15(1):39-44.
Vardi M, Nini A. Phosphodiesterase inhibitors for
erectile dysfunction in patients with diabetes mellitus.
[Review] [49 refs]. Cochrane Database Syst Rev
2007;(1):CD002187
Vardi Y, Sprecher E, Gruenwald I. Logistic regression
and survival analysis of 450 impotent patients treated
with injection therapy: long-term dropout parameters..
Br J Urol 2000;163(2):467-470.
Vickers M A, De Nobrega A M, Dluhy R G.
Diagnosis and treatment of psychogenic erectile
dysfunction in a urological setting: Outcomes of 18
consecutive patients. Br J Urol 1993;149(5
SUPPL.):1258-1261.
Virag R. Indications and early results of sildenafil
(Viagra) in erectile dysfunction. Urology
1999;54(6):1073-1077.
Virag R. Intracavernous injection of papaverine for
erectile failure. 1982. Br J Urol 2002;167(2 Pt 2):1196
Virag R, Floresco J, Richard C. Impairment of shearstress-mediated
vasodilation of cavernous arteries in
erectile dysfunction. Int J Impot Res 2004;16(1):39­
42.
Vitezic D. A risk-benefit assessment of sildenafil in
the treatment of erectile dysfunction. [Review] [72
refs]. Drug Saf 2001;24(4):255-265.
von Heyden B, Donatucci C F, Kaula N et al.
Intracavernous pharmacotherapy for impotence:
selection of appropriate agent and dose. [Review] [23
refs]. Br J Urol 1993;149(5 Pt 2):1288-1290.
Valiquette L, Montorsi F, Hellstrom W J et al. Penetration and
maintenance of erection with vardenafil: a time-from-dosing
analysis. Can J Urol 2005;12(3):2687-2698.
D-122